Home Concept of experimental preparation for treating dentin hypersensitivity
Article Open Access

Concept of experimental preparation for treating dentin hypersensitivity

  • Marta Tanasiewicz , Mirosław Gibas , Małgorzata Skucha-Nowak EMAIL logo , Henryk Twardawa and Agnieszka Machorowska-Pieniążek
Published/Copyright: October 22, 2016

Abstract

Background

Dentinal hypersensitivity (DH) is a diagnostic and therapeutic problem that is now appearing more frequently in modern dentistry. The aim of this work was to elaborate formulation of a new, original desensitizing preparation with prolonged action based on the knowledge of similar commercializations and to compare their performance in vitro.

Methodology

The analyses were performed with the aid of NMR spectroscopy. The experimental and commercial preparations were examined in vitro after thermocycling on human teeth by optical microscopy. The presence of the material on tooth tissue, its ability to penetrate into the tooth structure and its layer thickness were subjected to statistical analysis.

Results

A detailed knowledge on composition of commercial material was achieved from spectroscopic measurements. A new adhesive monomer was synthesized and incorporated into an experimental desensitizing formulation. The new monomer appeared to have comparable performance to the commercial one when regarding the affinity to tooth tissue and resistance to thermocycling.

Conclusions

The experimental formulation comprising a new adhesive monomer seems to be promising and could be applied in dental practice providing that biocompatibility is satisfactory.

1 Introduction

Dentinal hypersensitivity (DH) is a diagnostic and therapeutic problem now appearing more frequently in modern dentistry. The reasons for this ailment have not been explained until now. Dentin hypersensitiveness seems to be connected with irritation of nerve endings at a dentin/ pulp boundary in response to thermal, chemical, mechanical, dehydrative and osmotic stimuli. As a result, an acute pain of various intensities arises which can not be explained by other teeth diseases [1]. Indicating the type of treatment is problematic in dentistry since establishing reasons behind DH is difficult.

DH may arise from teeth having dentinal tubules that are exposed at the surface and patent to the pulp. There are other theories of DH but the most widely accepted is the hydrodynamic one, proposed c.a. 100 years ago by Gysi, described in detail and modified by Brannstorn in the 1960s [2,3]. The theory assumes that irritation of nerve fibers neighboring to odontoblasts and in initial sections of dentinal tubules is caused by a sudden bulk flow of tubular fluid in the presence of an irritating stimulus. As shown by scanning electron miscroscopy (SEM) investigations, hypersensitive teeth have 8-fold number of dentinal tubules with twofold diameter compared to the “normal” tooth, which causes greater flow of tubular fluid and intensification of symptoms [2].

Sensitivity to a thermal stimulus is the most distinct symptom of DH. The intensity of the pain felt depends on the psychic condition of the patient, their subjective reaction to the pain, and even on the season in the year. Pain occurs most frequently during brushing, consumption of either cold or hot drinks, and inhalation of cold air. The ailment may concern a single tooth or a number of teeth. Dentinal hypersensitivity happens mainly in adults, and most frequently in the cuspids, premolars, incisors and molars [4]. The factors and methods known to abolish DH may be divided into three following basic groups.

  1. Physical factors act on the basis of destroying nerve conduction in some area of the dentin. Methods of treatment include application of laser radiation, where a high energy laser beam is used to partially melt and thus block dentin tubules. This reduces sensitivity to nerve impulses and decreases nerve conduction speed [5,6].

  2. Physicochemical methods are based on introduction of some chemicals into dentinal tubules and application of an electric current. That can be ionophoresis with use of 1-2% NaF and a direct current of 1-5mA. The electric current enhances uptake of fluoride ions by a dentin which results in obliteration of dentinal tubules. When supplied electrophoretically into tubules, the fluoride ions penetrate deeper and are less susceptible to be washed out than those applied in a classic way [7].

  3. Chemical factors - chemicals include various inorganic and organic compounds, such as fluorine compounds (sodium fluoride, sodium fluorosilicate, tin fluoride, amine hydrofluorides), calcium compounds (calcium phosphate), oxalates (ferric oxalate and aluminum oxalate), strontium compounds (strontium chloride), protein precipitating agents (glutaraldehyde), adhesive and non-adhesive resins, potassium compounds (potassium nitrate), etc. The mode of therapeutic action of some chemicals is given in Table 1 [3, 4].

Table 1

Therapeutic action of selected ingredients of dentinal desensitizing preparations

IngredientTherapeutic action
Sodium fluoride (NaF)Blocks dentinal tubules by reaction with calcium contained in tubular fluid and resulting formation of calcium fluoride deposits
Strontium chloride (SrCl2)Prevents rapid flow of tubular fluid. Blocks nerve conduction biochemically
HEMA (2-hydroxyethyl methacrylate)Facilitates diffusion of sodium fluoride and potassium nitrate, creates a barrier in dentinal tubules preventing flow of tubular fluid
hydroxyapatite Ca10(PO4)6(OH)2Blocks dentinal tubules
Cetylamine hydrofluorideIncrease dentition immunity to caries
Potassium nitrate (KNO3)Generates K+ ions which influence biochemical transformations in nerve endings; as a result nerve conduction is destroyed and relief of pain is achieved
Aluminum lactatePrevents gingival bleeding
Vitamin E, provitamin B5Exhibit anti-inflammatory properties, facilitate regeneration of oral mucosa epithelium

As early as 1935 Grossman specified properties of preparations applied to abolish dentinal hypersensitivity. These properties should:

  1. be mild in respect to a pulp,

  2. not irritate a pulp,

  3. rapidly yield desired therapeutic effect,

  4. provide long-term therapeutic effect,

  5. be easy to apply,

  6. not cause pain during application,

  7. not discolor teeth [1].

A variety of desensitizing preparations are available on the dental materials market, including toothpastes, mouthwashes, gels and other dentifrices, to be used in a domestically, as well as more sophisticated materials to be applied in a dental clinic. Those include formulations designed to exhibit a long-term action, which is realized by incorporation of therapeutic ingredients into a polymeric matrix formed directly on to a tooth surface either via photopolymerization of (meth)acrylate resins, similarly as in the case of light-cured bonding agents and adhesive resins, or by evaporation of a volatile solvent in the case of varnish-type materials. Some of most known commercial materials of that type are listed in Table 2. The data on basic ingredients specified are derived from producers’ leaflets and available material safety data sheets.

Table 2

Composition of selected commercial dentinal desensitizing agents

Material (manufacturer)Basic ingredients
Seal&Protect (Dentsply DeTrey GmbH, Konstanz, Germany)di- and trimethacrylate resins, PENTA, functionalized amorphous silica, photoinitiators, BHT, cetylamine hydrofluoride, triclosan, acetone
Gluma Comfort Bond + Desensitizer (Heraeus KulzerGmbH, Hanau, Germany)ethanol, HEMA, poly(methacrylic-oligo-acrylic acid), 4-META, glutaraldehyde
Admira Protect (Voco GmbH, Cuxhaven, Germany)acetone, bis-GMA, acidic adhesive monomer, ormocer, HEMA, urethanedimethacrylate, catalyst
Fluor Protector (Ivoclar Vivadent, Liechtenstein)difluorosilane, polyurethane varnish, ethyl acetate, isoamyl propionate
Bifluorid 10 (Voco GmbH, Cuxhaven, Germany)ethyl acetate, cellulose nitrate, isopentyl propionate, sodium fluoride, clove oil

PENTA: dipentaerythriol pentaacrylate monophosphate; BHT: butylated hydroxytoluene (2,6-di-t-butyl-p-cresol); HEMA: 2-hydroxyethyl methacrylate;

4-META: 4-methacryloxyethyltrimellitic acid anhydride;

bis-GMA: 2,2-bis[4-(2-hydroxy-3-methacryloyloxypropyl)phenyl] propane

The objective of this work is to elaborate an original, experimental formulation designed to diminish dentinal hypersensitivity in the long-term. To aid the research we have estimated quantitative composition of selected commercial products using nuclear magnetic resonance spectroscopy (NMR). The main chemical novelty comprises introduction of a new adhesive monomer, pyromellitic methacrylate anhydride (PMMAn), having the structure shown below. From point of view of chemical structure, PMMAn looks similar to two well-known dental adhesive monomers: 4-META and PMDM, contained in many adhesive formulations (Figure 1) [8].

Figure 1 Structure of PMDM, 4-META and PMMAn adhesive monomers
Figure 1

Structure of PMDM, 4-META and PMMAn adhesive monomers

The formulation was tested in vitro to estimate affinity to human tooth structure. In the next step, immunological response on appropriate cell cultures was evaluated. If results appeared to be positive, behavioral tests on rats will be conducted, prior to clinical trials on humans.

2 Methods

Analyses: 1H NMR spectra were recorded using UNITY/ INOVA 300MHz NMR spectrometer (Varian). The samples were tested as solutions in deuteriated acetone containing tetramethylsilane (TMS) as a chemical shift internal standard. Infra-red spectra were recorded using FT-IR Nicolet 6700 spectrophotometer. DSC analysis was performed using METTLER-TOLEDO (DSC822e) instrument.

Chemicals: Bis-GMA resin was synthesized as previously reported [9]. PMDA (pyromellitic anhydride; 1,2,4,5-benzenetetracarboxylic anhydride, Aldrich) was recrystallized from acetic anhydride. HEMA (2-hydroxyethyl methacrylate, Sigma) and acetone (POCh) were dried over anhydrous magnesium sulphate. TEGDMA (triethylene glycol dimethacrylate, Fluka), HMDI (hexamethylene diisocyanate, Fluka), DBTDL (dibutyltin dilaurate, Fluka), HA (hydroxyapatite nanopowder, Aldrich), triclosan (irgasan; 5-chloro-2-(2,4-dichlorophenoxy)phenol, Sigma Aldrich), KF (potassium fluoride, UCB), DMAEMA (N, N-dimethylaminoethyl methacrylate, Merck), CQ (camphorquinone, Aldrich) as well as other auxiliary reagents and solvents were used as supplied.

Additionally, samples of commercial UDMA resin (urethane dimethacrylate; PLEX 6661, Röhm GmbH) and TMPTMA (trimethylolpropane trimethacrylate, Aldrich) were subjected to comparative NMR measurements.

Syntheses: Methacrylate resin: The modified patented recipe was applied. Thus, 6g of bis-GMA resin, 4g of TEGDMA and catalytic amount of DBTDL (0.05% by weight) were homogenized manually by stirring with a glass rod with gentle heating. After that, 0.3g of HMDI was added dropwise whilst the mixture was magnetically stirred at 40°C for 4hrs. The product was left to stand overnight in a thermostat at 40°C. According to stoichiometry and our previous findings [9] the resin should contain ca. 20% by weight of bis-GMA/HMDI adduct as well as TEGDMA and unreacted bis-GMA.

2.1 PMMAn adhesive monomer

1.00g (0.00467mole) PMDA, 0.596g (0.00467mole) HEMA and 0.064g DMAEMA (catalyst, 4% by weight in respect to the reagents) were dissolved in 12.77g of anhydrous acetone and stirred magnetically at room temperature for 2hrs 15min. Evaporation of acetone yielded a semi-solid crude product. 1.14g of the product was dissolved in 1ml of acetone and resulting solution was added dropwise to 4ml of hexane/dichlorometane 1:1 (v/v) mixture. Precipitate formed and was filtered off and the filtrate was mixed with 5ml of hexane. Again precipitate appeared which was filtered off and the filtrate was shaken with 3 ml of hexane. After 3min a delicate, white precipitate appeared, which after filtering and drying under vacuum consisted of the pure product with final yield of 33%.

2.2 In vitro tests on human teeth

The experiments were performed on 28 random, undamaged human teeth that were extirpated due to prosthetic indications belonging to 2 patient groups, with 14 teeth in each group. Dentin was exposed by polishing with grade 1000 abrasive paper in a water stream. Seal&Protect and experimental desensitizing formulation (EDF), both tinted with eosin to enable visual observation, were applied on to the dentin surface and cured for 40s with HILUX 200 polymerization lamp. After that, the teeth were subjected to 1000 variable temperature cycles (5 and 55°C alternatively, for 30s each) using EMT-SYSTEMS thermocycler. Next, the teeth were cut along the axial plane with EVA type prosthetic cutting-off machine to visualize thickness of the preparation layers and its penetration into tooth tissues. Microsections and cross-sections were examined with the aid of KAPS Asslar/Wetzlar type SOM 62 optical microscope coupled with a Nikon digital camera.

2.3 Statistical analysis

Statistics was employed to compare the formulations by estimation of differences in population of particular features, i.e. the amount of material present at the tooth surface in the microsection and cross-sections of the teeth. Chi2 squared independence test with Yates correction and/or Fisher’s exact test were applied. All the tests were carried out at a significance level a= 0.05 using the Statistica 6.0 software (SUM, Katowice, Poland).

3 Results and discussion

3.1 NMR analysis of Seal&Protect composition

Table 2 shows that manufacturers do not disclose precise information on the composition of commercial formulations. For instance, one does not know what particular species are di- and trimethacrylate resins contained in Seal&Protect or which adhesive monomer is used in Admira Protect. Quantitative composition is not revealed at all. Theretofore, we have analyzed composition of Seal&Protect using NMR spectroscopy. This technique enables identification and quantitative analysis of mixtures of organic compounds in solution. Thus, no information on the content of silica nanofiller, which is an inorganic compound, could be achieved from reading NMR spectra.

Figure 2 presents a set of 1H NMR spectra, recorded for the aliphatic resonances region for Seal&Protect and two methacrylate resins widely used in dentistry, i.e. UDMA and TMPTMA. We ascertained monomers contained in Seal&Protect to be di- and trimethacrylate resins since the spectra contained characteristic signals of both UDMA and TMPTMA. Characteristic UDMA spectral patterns are clearly seen at δ=2.8-3.2ppm and δ=0.9-1.0ppm, whereas for TMPTMA the most characteristic signal is the quartet at δ=1.64ppm and triplet at δ=0.98ppm. Methacrylate methyl groups from both UDMA and TMPTMA give overlapping signals at δ=1.92ppm. Additional signals identified are those of acetone solvent (singlet at δ=2.10ppm) and cetylamine moiety (triplet at δ=2.72ppm).

Figure 2 1H NMR spectra of Seal&Protect (upper), UDMA (middle) and TMPTMA (lower run); aliphatics absorption range; A – acetone, C – cetylamine, T – TMPTMA, U – UDMA.
Figure 2

1H NMR spectra of Seal&Protect (upper), UDMA (middle) and TMPTMA (lower run); aliphatics absorption range; A – acetone, C – cetylamine, T – TMPTMA, U – UDMA.

Another informative region of NMR spectra is that of vinylic and aromatic proton absorption, presented in Figure 3. Besides the signals of acrylate and methacrylate vinylic protons from PENTA (δ=5.8-6.5ppm) and methacrylate resins (δ=5.6-6.1ppm), a set of signals is seen in the range 8=6.8-7.4ppm matching exactly for those of a triclosan sample. Additionally, two doublets at δ=6.73 and 7.84ppm could be assigned to aromatic protons in ethyl 4-(dimethylamino)benzoate, a commonly used reducing agent in camphorquinone based photoinitiating system [10].

Figure 3 1H NMR spectra of Seal&Protect (upper) and triclosan (lower run); aromatics and vinylics absorption range.
Figure 3

1H NMR spectra of Seal&Protect (upper) and triclosan (lower run); aromatics and vinylics absorption range.

Based on the above assignments and integral intensities of particular signals we could calculate molar percentages for identified components, and using the respective molecular weights, recalculate those to weight percentages. The data are collected in the Table 3.

Table 3

NMR based quantitative data on Seal&Protect composition (organics only)

IngredientMolar percentageMolecular weightWeight percentage
UDMA5.5470.5624.3
TMPTMA5.1338.4016.2
PENTA1.3604.527.4
Triclosan1.2289.543.3
Cetylamine hydrofluoride0.4261.481.0
Ethyl dimethylaminobenzoate*0.5193.241.0
Acetone86.058.0846.8

* Since this compound was found in the material, one could suspect also presence of camphorquinone as photoinitiator at the level of below 1%. However, the signals of the latter, if present, are hidden under intense signals of the monomers in the aliphatics region.

3.2 Synthesis of PMMAn

The new adhesive monomer, PMMAn, can be considered as an intermediate product in the synthesis of PMDM, a well known dental monomer (Figure 4). We have observed formation of such intermediates when synthesizing series of PMnEDM monomers [11]. To synthesize PMDM, two moles of HEMA must be reacted with one mole of PMDA [12]. When keeping equimolar HEMA to PMDA ratio, PMMAn is a main product. We have followed this reaction by 1H NMR spectroscopy - 2h 15 min conversion to PMMAn reaches a maximal value of 87% which enables separation of PMMAn from unreacted PMDA and HEMA, as well as small amount of PMDM formed, by the purification procedure, as described in the materials and methods part. Prolongation of the reaction time leads to decrease of PMMAn and increase of PMDM contents.

Figure 4 Reaction scheme in PMMAn synthesis.
Figure 4

Reaction scheme in PMMAn synthesis.

PMMAn is a new compound having the formal name: 5-(7-methyl-1,6-dioxo-2,5-dioxa-7-octenyl)trimellitate anhydride or, more briefly, 5-methacryloyloxyethyltrimellitate anhydride. The chemical structure is elucidated from IR and NMR data. In IR spectra, bands at ν=1785 and 1745 cm-1 show the presence of an anhydride group. 1H NMR spectra is given in Figure 5, and the following signals were assigned: aromatic hydrogens at δ=8.36 and 8.45ppm (two doublets 1H each, Jpara=0.73Hz); CH2= narrow multiplets 1H each at δ=5.65 and 6.11ppm; CH3- narrow multiplet 3H at δ=1.92ppm; ArCOOCH2- triplet 2H at δ=4.67ppm; -CH2-OCOC= triplet 2H at δ=4.51ppm. A melting endotherm was found by DSC at 153.99°, followed bxsy polymerization exotherm at 163.13°.

Figure 5 1H NMR spectrum of PMMAn.
Figure 5

1H NMR spectrum of PMMAn.

3.3 Preparation of experimental desensitizing formulation (EPF)

The composition of Seal&Protect as revealed by NMR analysis, indicates that desensitizing formulation of prolonged action basically consist of two groups of ingredients: those responsible for formation of stable polymeric layer (methacrylates, adhesive monomer, photoinitiating system) and those responsible for desensitization (triclosan, cetylamine hydrofluoride, silica nanofiller). Additionally, a volatile solvent (to be evaporated after application) facilitates penetration of the composition into a tooth structure.

The formulation investigated in this work complies with such an idea. The basic differences to Seal&Protect are another methacrylate resin, new adhesive monomer PMMAn, incorporation of hydroxyapatite instead of silica, and potassium fluoride as a source of potassium and fluoride ions. Moreover, addition of HEMA - hydrophilic monomer of low viscosity, enabled reduction of acetone solvent content considerably. The proposed percentages of particular species are collected in Table 4.

Table 4

Composition of the experimental desensitizing formulation (EPF)

IngredientFunction in the preparationWeight percentage
Methacrylate resinFormation of the crosslinked polymer matrix47.5
HEMAHydrophilic monomer8.4
PMMAnAdhesive monomer2.9
Hydroxyapatite nanopowderPotentially bioactive filler2.6
TriclosanAntibacterial action5.3
KFGeneration of potassium and fluoride ions0.8
CamphorquinonePhotoinitiator0.2
DMAEMAReducing agent for photoinitiator0.6
AcetoneSolvent31.7

3.4 In vitro experiments on human teeth

Application performance of the experimental and commercial materials was evaluated in vitro after intense thermocycling corresponding to long-term oral conditions. The main features observed were uniformity of the preparation layer at the surface of exposed dentin, penetration of the material into dentinal tubules and the layer thickness (Figure 6). The uniform layer was observed in 71% of samples coated with EDF and in 79% of those coated with the commercial product. Penetration of EDF into tubules was stated in 50% of samples coated with EDF and in 64% of samples coated with the commercial product. A uniform and considerably thick layer was found in 50% samples coated with EDF and in 21% of samples coated with the commercial product. However, differences in population of particular features when evaluated statistically appeared to be not significant. Thus, performance of both materials when tested in vitro appeared to be comparable (Figure 7).

Figure 6 Photograph of polished surface (A) and exposed dentin surface (B) both coated with the experimental material; micrograph of microsection (C), all after thermocycling.
Figure 6

Photograph of polished surface (A) and exposed dentin surface (B) both coated with the experimental material; micrograph of microsection (C), all after thermocycling.

Figure 7 The statistics of the in vitro experiment.
Figure 7

The statistics of the in vitro experiment.

4 Conclusions

Nuclear magnetic resonance spectroscopy is a powerful technique in determining constitution of methacrylate-based dental formulations which is especially important since manufacturers usually do not reveal full information on the constituents.

A new adhesive monomer PMMAn exhibited a good ability to adhere to dentin which was confirmed by in vitro experiments.

Durability of bonding to the tooth tissue of the experimental desensitizing formulation is comparable to that of a renowned commercial product.

New desentizing formulations of prolonged action based on adhesive systems should be exploited since they seem to be promising from clinical point of view.

The research should be continued towards evaluation of biocomatibility of the new material.

Conflict of interest

  1. The authors declare that they have no conflict of interest.

References

[1] Canadian Advisory Board on dentin hypersensitivity., Consensus based recommendations for the diagnosis and management of dentin hypersensitivity, J. Clin. Dent. Assoc., 2003, 69, 221-226Search in Google Scholar

[2] Orchardson R., Gillam D.G., Managing dentin hypersensitivity, JADA., 2009,137, 990-998.10.14219/jada.archive.2006.0321Search in Google Scholar

[3] Gillam D.G., Orchardson R., Advances in the treatment of root dentine sensitivity: mechanism and treatment principles, Endodontic Topics., 2006, 13, 13-3310.1111/j.1601-1546.2006.00209.xSearch in Google Scholar

[4] Jacobsen P., Bruce G., Clinical dentin hypersensitivity. Understanding the causes and prescribing a treatment, J. Dent. Practice., 2001, 2, 134-13810.5005/jcdp-2-1-27Search in Google Scholar

[5] Renton-Harper P., Midda M., Nd:YAG laser treatment of dentinal hypersensitivity, Br. Dent. J., 1992, 11, 13-1610.1038/sj.bdj.4807731Search in Google Scholar

[6] Orchardson R., Whitters C.J., Effect of HeNe and pulsed Nd:YAG laser irradiation on intradental nerve responses to mechanical stimulation of dentine, Lasers in Surg and Med., 2000, 26, 241-24910.1002/(SICI)1096-9101(2000)26:3<241::AID-LSM1>3.0.CO;2-ISearch in Google Scholar

[7] Carlo G.T., Cianncio S.G., Seyrek S.K., Evaluation of ionophoretic application of fluoride for tooth desensitization, JADA., 1985, 11, 761-765Search in Google Scholar

[8] Van Landuyt K., Snauwaert J., De Munck J., Peumans M., Yoshida Y., Poitevin A., et al., Systematic review of the chemical composition of contemporary dental adhesives, Biomaterials., 2007, 28, 3757-378510.1016/j.biomaterials.2007.04.044Search in Google Scholar

[9] Gibas M., Szapska B., Preparation of dental composite material with low water sorption, Pol. J. Appl. Chem., 1993, 37, 277-289Search in Google Scholar

[10] Moszner N., Salz U., Zimmerman J., Chemical aspects of self-etching enamel-dentin adhesives: A systematic review, Dent. Mater., 2005, 21, 895-91010.1016/j.dental.2005.05.001Search in Google Scholar

[11] Kupka T.W., Gibas M., Dąbrowska A., Tanasiewicz M., Malec W., Experimental dental bio-adhesives for direct restorations. Influence of PMnEDM homologs structure on bond strength, Dent. Mater., 2007, 23, 1269-127510.1016/j.dental.2006.11.019Search in Google Scholar

[12] Farahani M., Johnston A.D., Bowen R.L., The Effect of Catalyst Structure on the Synthesis of a Dental Restorative Monomer, J. Dent. Res., 1991, 70, 67-7110.1177/00220345910700011101Search in Google Scholar

Received: 2015-9-17
Accepted: 2016-8-8
Published Online: 2016-10-22
Published in Print: 2016-10-1

© 2016 M. Tanasiewicz et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Research Article
  2. The possible molecular regulation mechanism of CIK cells inhibiting the proliferation of Human Lung Adenocarcinoma NCL-H157 Cells
  3. Case Report
  4. Urethral stone of unexpected size: case report and short literature review
  5. Case Report
  6. Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report
  7. Research Article
  8. FPL tendon thickness, tremor and hand functions in Parkinson’s disease
  9. Research Article
  10. Diagnostic value of circulating tumor cells in cerebrospinal fluid
  11. Research Article
  12. A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma
  13. Research Article
  14. MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression
  15. Research Article
  16. Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction
  17. Research Article
  18. The role of interleukin genes in the course of depression
  19. Case Report
  20. A rare case of primary pulmonary diffuse large B cell lymphoma with CD5 positive expression
  21. Research Article
  22. DWI and SPARCC scoring assess curative effect of early ankylosing spondylitis
  23. Research Article
  24. The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer
  25. Case Report
  26. Dysphonia – the single symptom of rifampicin resistant laryngeal tuberculosis
  27. Review Article
  28. Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
  29. Research Article
  30. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer
  31. Research Article
  32. Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction
  33. Research Article
  34. Blood cells in thyroid cancer patients: a possible influence of apoptosis
  35. Research Article
  36. Detected EGFR mutation in cerebrospinal fluid of lung adenocarcinoma patients with meningeal metastasis
  37. Mini-review
  38. Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia
  39. Research Article
  40. GSTP1 A>G polymorphism and chemosensitivity of osteosarcoma: A meta-analysis
  41. Research Article
  42. A meta-analysis of adiponectin gene rs22411766 T>G polymorphism and ischemic stroke susceptibility
  43. Research Article
  44. The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
  45. Research Article
  46. SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24
  47. Research Article
  48. Sevoflurane affects evoked electromyography monitoring in cerebral palsy
  49. Case Report
  50. A case report of hereditary spherocytosis with concomitant chronic myelocytic leukemia
  51. Case Report
  52. A case of giant saphenous vein graft aneurysm followed serially after coronary artery bypass surgery
  53. Research Article
  54. LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
  55. Review Article
  56. Meningioma recurrence
  57. Case Report
  58. Endobronchial amyloidosis mimicking bronchial asthma: a case report and review of the literature
  59. Case Report
  60. A confusing case report of pulmonary langerhans cell histiocytosis and literature review
  61. Research Article
  62. Effect of hesperetin on chaperone activity in selenite-induced cataract
  63. Research Article
  64. Clinical value of self-assessment risk of osteoporosis in Chinese
  65. Research Article
  66. Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
  67. Research Article
  68. Is acute appendicitis still misdiagnosed?
  69. Retraction
  70. Retraction of: application of food-specific IgG antibody detection in allergy dermatosis
  71. Review Article
  72. Platelet Rich Plasma: a short overview of certain bioactive components
  73. Research Article
  74. Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis
  75. Review Article
  76. Standards of anesthesiology practice during neuroradiological interventions
  77. Research Article
  78. Expression and clinical significance of LXRα and SREBP-1c in placentas of preeclampsia
  79. Letter to the Editor
  80. ARDS diagnosed by SpO2/FiO2 ratio compared with PaO2/FiO2 ratio: the role as a diagnostic tool for early enrolment into clinical trials
  81. Research Article
  82. Impact of sensory integration training on balance among stroke patients: sensory integration training on balance among stroke patients
  83. Review Article
  84. MicroRNAs as regulatory elements in psoriasis
  85. Review Article
  86. Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
  87. Review Article
  88. Garengeot’s hernia: two case reports with CT diagnosis and literature review
  89. Research Article
  90. Concept of experimental preparation for treating dentin hypersensitivity
  91. Research Article
  92. Hydrogen water reduces NSE, IL-6, and TNF-α levels in hypoxic-ischemic encephalopathy
  93. Research Article
  94. Xanthogranuloma of the sellar region diagnosed by frozen section
  95. Case Report
  96. Laparoscopic antegrade cholecystectomy: a standard procedure?
  97. Case Report
  98. Maxillary fibrous dysplasia associated with McCune-Albright syndrome. A case study
  99. Regular Article
  100. Sialoendoscopy, sialography, and ultrasound: a comparison of diagnostic methods
  101. Research Article
  102. Antibody Response to Live Attenuated Vaccines in Adults in Japan
  103. Conference article
  104. Excellence and safety in surgery require excellent and safe tutoring
  105. Conference article
  106. Suggestions on how to make suboptimal kidney transplantation an ethically viable option
  107. Regular Article
  108. Ectopic pregnancy treatment by combination therapy
  109. Conference article
  110. Use of a simplified consent form to facilitate patient understanding of informed consent for laparoscopic cholecystectomy
  111. Regular Article
  112. Cusum analysis for learning curve of videothoracoscopic lobectomy
  113. Regular Article
  114. A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson’s disease susceptibility
  115. Conference article
  116. Plastination: ethical and medico-legal considerations
  117. Regular Article
  118. Investigation and control of a suspected nosocomial outbreak of pan-drug resistant Acinetobacter baumannii in an intensive care unit
  119. Regular Article
  120. Multifactorial analysis of fatigue scale among nurses in Poland
  121. Regular Article
  122. Smoking cessation for free: outcomes of a study of three Romanian clinics
  123. Regular Article
  124. Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis
  125. Special Issue on Italian Society for the Study of Vascular Anomalies
  126. Prevention and treatment of peritoneal adhesions in patients affected by vascular diseases following surgery: a review of the literature
  127. Special Issue on Italian Society for the Study of Vascular Anomalies
  128. Surgical treatment of recidivist lymphedema
  129. Special Issue on Italian Society for the Study of Vascular Anomalies
  130. CT and MR imaging of the thoracic aorta
  131. Special Issue on Italian Society for the Study of Vascular Anomalies
  132. Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma
  133. Special Issue on Italian Society for the Study of Vascular Anomalies
  134. Sternal reconstruction by extracellular matrix: a rare case of phaces syndrome
  135. Special Issue on Italian Society for the Study of Vascular Anomalies
  136. Prenatal diagnosis, 3-D virtual rendering and lung sparing surgery by ligasure device in a baby with “CCAM and intralobar pulmonary sequestration”
  137. Special Issue on Italian Society for the Study of Vascular Anomalies
  138. Serum levels of inhibin B in adolescents after varicocelelectomy: A long term follow up
  139. Special Issue on Italian Society for the Study of Vascular Anomalies
  140. Our experience in the treatment of Malignant Fibrous Hystiocytoma of the larynx: clinical diagnosis, therapeutic approach and review of literature
  141. Special Issue on Italian Society for the Study of Vascular Anomalies
  142. Delayed recurrent nerve paralysis following post-traumatic aortic pseudoaneurysm
  143. Special Issue on Italian Society for the Study of Vascular Anomalies
  144. Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: report of a case and review of the literature
  145. Special Issue on Italian Society for the Study of Vascular Anomalies
  146. Celiac axis compression syndrome: laparoscopic approach in a strange case of chronic abdominal pain in 71 years old man
  147. Special Issue on Italian Society for the Study of Vascular Anomalies
  148. A rare case of persistent hypoglossal artery associated with contralateral proximal subclavian stenosis
  149. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  150. Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients
  151. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  152. Professional dental and oral surgery liability in Italy: a comparative analysis of the insurance products offered to health workers
  153. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  154. Informed consent in robotic surgery: quality of information and patient perception
  155. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  156. Malfunctions of robotic system in surgery: role and responsibility of surgeon in legal point of view
  157. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  158. Medicolegal implications of surgical errors and complications in neck surgery: A review based on the Italian current legislation
  159. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  160. Iatrogenic splenic injury: review of the literature and medico-legal issues
  161. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  162. Donation of the body for scientific purposes in Italy: ethical and medico-legal considerations
  163. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  164. Cosmetic surgery: medicolegal considerations
  165. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  166. Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues
  167. Review Article
  168. Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia
  169. Review Article
  170. Endoscopic diagnosis and treatment of neuroendocrine tumors of the digestive system
  171. Review Article
  172. Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia
  173. Research Article
  174. Relationship between gastroesophageal reflux disease and Ph nose and salivary: proposal of a simple method outpatient in patients adults
  175. Case Report
  176. Idiopathic pleural panniculitis with recurrent pleural effusion not associated with Weber-Christian disease
  177. Research Article
  178. Morbid Obesity: treatment with Bioenterics Intragastric Balloon (BIB), psychological and nursing care: our experience
  179. Research Article
  180. Learning curve for endorectal ultrasound in young and elderly: lights and shades
  181. Case Report
  182. Uncommon primary hydatid cyst occupying the adrenal gland space, treated with laparoscopic surgical approach in an old patient
  183. Research Article
  184. Distraction techniques for face and smile aesthetic preventing ageing decay
  185. Research Article
  186. Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC
  187. Review Article
  188. Descending necrotizing mediastinitis in the elderly patients
  189. Research Article
  190. Prophylactic GSV surgery in elderly candidates for hip or knee arthroplasty
  191. Research Article
  192. Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer
  193. Research Article
  194. The learning curve of laparoscopic holecystectomy in general surgery resident training: old age of the patient may be a risk factor?
  195. Research Article
  196. Self-gripping mesh versus fibrin glue fixation in laparoscopic inguinal hernia repair: a randomized prospective clinical trial in young and elderly patients
  197. Research Article
  198. Anal sphincter dysfunction in multiple sclerosis: an observation manometric study
Downloaded on 21.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2016-0070/html
Scroll to top button